JPH02295463A - Food material for improving hepatic function - Google Patents
Food material for improving hepatic functionInfo
- Publication number
- JPH02295463A JPH02295463A JP1115122A JP11512289A JPH02295463A JP H02295463 A JPH02295463 A JP H02295463A JP 1115122 A JP1115122 A JP 1115122A JP 11512289 A JP11512289 A JP 11512289A JP H02295463 A JPH02295463 A JP H02295463A
- Authority
- JP
- Japan
- Prior art keywords
- egg white
- food material
- mixture
- hepatic function
- hydrolyzate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003908 liver function Effects 0.000 title claims abstract description 8
- 235000013305 food Nutrition 0.000 title claims abstract description 6
- 239000000463 material Substances 0.000 title abstract description 4
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims abstract description 38
- 235000014103 egg white Nutrition 0.000 claims abstract description 38
- 210000000969 egg white Anatomy 0.000 claims abstract description 38
- 108010000912 Egg Proteins Proteins 0.000 claims abstract description 37
- 102000002322 Egg Proteins Human genes 0.000 claims abstract description 37
- 238000000354 decomposition reaction Methods 0.000 claims description 18
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108091005804 Peptidases Proteins 0.000 abstract description 3
- 102000035195 Peptidases Human genes 0.000 abstract description 3
- 102000016943 Muramidase Human genes 0.000 abstract description 2
- 108010014251 Muramidase Proteins 0.000 abstract description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 abstract description 2
- 239000013543 active substance Substances 0.000 abstract description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 2
- 229960000274 lysozyme Drugs 0.000 abstract description 2
- 239000004325 lysozyme Substances 0.000 abstract description 2
- 235000010335 lysozyme Nutrition 0.000 abstract description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 abstract 2
- 235000011037 adipic acid Nutrition 0.000 abstract 1
- 239000001361 adipic acid Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 30
- 239000000047 product Substances 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 229940088598 enzyme Drugs 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 230000002255 enzymatic effect Effects 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- JYJFNDQBESEHJQ-UHFFFAOYSA-N 5,5-dimethyloxazolidine-2,4-dione Chemical compound CC1(C)OC(=O)NC1=O JYJFNDQBESEHJQ-UHFFFAOYSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000000378 dietary effect Effects 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- QIZPVNNYFKFJAD-UHFFFAOYSA-N 1-chloro-2-prop-1-ynylbenzene Chemical compound CC#CC1=CC=CC=C1Cl QIZPVNNYFKFJAD-UHFFFAOYSA-N 0.000 description 2
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000004278 EU approved seasoning Substances 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- -1 Sodium chloride Potassium carbonate Calcium hydroxide Calcium monophosphate Magnesium chloride Chemical compound 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 235000013736 caramel Nutrition 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000019534 high fructose corn syrup Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000003228 microsomal effect Effects 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 229940035023 sucrose monostearate Drugs 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- VZXYYOVRWYITIT-UHFFFAOYSA-N calcium;pyridine-3-carboxamide Chemical compound [Ca].NC(=O)C1=CC=CN=C1 VZXYYOVRWYITIT-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229950004446 dimethadione Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000011640 ferrous citrate Substances 0.000 description 1
- 235000019850 ferrous citrate Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- IRYJRGCIQBGHIV-UHFFFAOYSA-N trimethadione Chemical compound CN1C(=O)OC(C)(C)C1=O IRYJRGCIQBGHIV-UHFFFAOYSA-N 0.000 description 1
- 229960004453 trimethadione Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 235000021413 well-balanced diet Nutrition 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Meat, Egg Or Seafood Products (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は,卵白酵素分解物からなる肝機能改善食材に関
する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a liver function-improving food product comprising an egg white enzyme decomposition product.
肝臓疾患の治療として,安静療法,薬物療法などと共に
,食事療法が一般的に行われている。Dietary therapy is commonly used as a treatment for liver disease, along with bed rest and drug therapy.
肝臓疾患では,蛋白,脂肪などの吸収,消化及び代謝が
障害され,その結果栄養不良状態を生じている場合が多
い。Liver diseases often impair the absorption, digestion, and metabolism of proteins and fats, resulting in malnutrition.
そのような場合に食事療法として,消化管からの吸収が
良く,栄養分に過不足がないバランスの良い食事を与え
ることが,多く行われている。In such cases, dietary therapy is often performed by providing a well-balanced diet that is easily absorbed from the gastrointestinal tract and contains neither excess nor deficiency of nutrients.
本発明者は,食事療法に適した素材を提供すべく種々検
討した結果,卵白を蛋白分解酵素で分解して得られる卵
白酵素分解物が,従来食事療法に用いられている蛋白質
それ自体及び該蛋白質と同じ構成のアミノ酸混合物に比
し,肝機能の回復力を著しく高めることを見い出し,本
発明を完成した。As a result of various studies in order to provide materials suitable for dietary therapy, the present inventor found that the enzyme-degraded egg white obtained by decomposing egg white with proteolytic enzymes contains the protein itself and the protein that is conventionally used in dietary therapy. The present invention was completed based on the discovery that the recovery power of liver function is significantly enhanced compared to an amino acid mixture having the same composition as protein.
本発明に用いられる卵白酵素分解物は,生卵白,乾燥卵
白,農縮卵白,凍結卵白,あるいはリゾチームやアビジ
ンのような生理活性物質を除いた卵白を,蛋白分解酵素
で処理して得られるものであればよい。例えば,本出願
人が先に出願した特開昭63−14681号に開示され
ている製法で製造される卵白酵素分解物を用いることが
できる。The enzymatically degraded egg white used in the present invention is obtained by treating raw egg white, dried egg white, agriculturally reduced egg white, frozen egg white, or egg white from which physiologically active substances such as lysozyme and avidin have been removed with a proteolytic enzyme. That's fine. For example, it is possible to use an egg white enzymatic decomposition product produced by the production method disclosed in Japanese Patent Application Laid-Open No. 14681/1983, which was previously filed by the present applicant.
本発明の肝機能改善食材は,卵白酵素分解物それ自体で
構成されてもよいが,卵白酵素分解物を脂肪,糖質(澱
粉,デキス} IJン,砂糖等),ビタミン及びミネラ
ルなど他の栄養素や栄養補助成分と組み合わせたもので
あってもよい。The liver function improving food of the present invention may be composed of the egg white enzymatic decomposition product itself, but the egg white enzymatic decomposition product may be combined with other ingredients such as fat, carbohydrates (starch, dextrin, sugar, etc.), vitamins and minerals. It may also be in combination with nutrients or nutritional supplements.
本発明の肝機能改善食材は,実施例で示すように,顆粒
剤として,あるいは経口経腸栄養剤,ジュース,ビスケ
ットに添加して用いるのがよいが,他の食品,例えば食
パン,スープ,牛乳,スポーツ飲料,ドリンク剤,鳥獣
肉類,魚肉水産肉類,果実類,化学調味料,天然調味料
などに添加してもよい。As shown in the Examples, the liver function-improving foodstuff of the present invention is preferably used in the form of granules or added to oral and enteral nutritional supplements, juices, and biscuits; It may be added to sports drinks, drinks, poultry and animal meat, fish and marine products, fruits, chemical seasonings, natural seasonings, etc.
以下,実験例及び実施例をあげて本発明を具体的に説明
するが,これらは本発明を限定するものではない。The present invention will be specifically explained below with reference to experimental examples and examples, but these are not intended to limit the present invention.
実験例および実施例においては,次の方法で製造した卵
白酵素分解物を使用した。乾燥卵白を水に固形分796
になるように溶かし, 0.11’J塩酸でpH 3.
0に調節した。これにリゾプス( Rhizopua)
属由来のオリエンターゼ5A(阪急共栄物産(株))を
固形分に対し396加え,40°Cで5時間,ついで5
00Cで11時間酵素分解した。分解終了後, pH6
.0に中和し,80〜1006Cで加熱濾過した。In the experimental examples and examples, an egg white enzymatic decomposition product produced by the following method was used. Dry egg whites in water to a solid content of 796
Dissolve to pH 3. with 0.11'J hydrochloric acid.
Adjusted to 0. This is Rhizopus (Rhizopua)
Orientase 5A derived from the genus (Hankyu Kyoei Bussan Co., Ltd.) was added at 396% of the solid content, and heated at 40°C for 5 hours, and then incubated at 40°C for 5 hours.
Enzymatic digestion was performed at 00C for 11 hours. After completion of decomposition, pH 6
.. The mixture was neutralized to 0 and heated and filtered at 80 to 1006C.
この濾液を噴霧乾燥して,卵白酵素分解物の粉末(分解
率19%)を得た。This filtrate was spray-dried to obtain a powder of egg white enzyme decomposition product (decomposition rate: 19%).
実験例
(1)肝機能の評価方法
卵白酵素分解物の肝機能改善効果を確認するために,ト
リメタジオン(以下TMO)負荷試験(肝切除モデルに
おける肝ミクロゾーム機能の測定二日本外科学会雑誌,
第羽回,第3号,303〜307頁, 1987年)に
従い試験した。Experimental example (1) Evaluation method of liver function In order to confirm the liver function-improving effect of egg white enzymatic decomposition, trimethadione (hereinafter TMO) loading test (measurement of liver microsomal function in a liver resection model) was carried out.
The test was carried out in accordance with the Japanese Journal, No. 3, pp. 303-307, 1987).
この試験は,肝ミクロゾーム機能を数量的にとらえるこ
とができ,肝機能の臨床診断に利用されるものである。This test can quantify liver microsomal function and is used for clinical diagnosis of liver function.
(2)試料
試料として,上記の卵白酵素分解物(分解率195%)
を使用した。また,対照として,卵白及び表1に示す如
き卵白と同じアミノ酸組成を有するアミノ酸混合物を使
用した。(2) As a sample, the above egg white enzyme decomposition product (degradation rate 195%)
It was used. In addition, as a control, egg white and an amino acid mixture having the same amino acid composition as the egg white as shown in Table 1 were used.
試料及び対照の窒素含量を同一(2.2596)にそろ
えるために,α−コンスターチを使用して,卵白酵素分
解物は含ffi 17.77 96に,卵白は含ffi
16.00 % lこ.またアミノ酸混合物は含量1
5.55 96に調整した。In order to make the nitrogen content of the sample and the control the same (2.2596), α-cornstarch was used to make the egg white enzymatically digested product contain ffi 17.77 96, and the egg white contain ffi
16.00% lko. Also, the amino acid mixture has a content of 1
Adjusted to 5.55 96.
表1 アミノ酸混合物のアミノ酸組成 (計5回)に経口投与して,肝障害ラットを作製した。Table 1 Amino acid composition of amino acid mixture (5 times in total) to produce liver-damaged rats.
四塩化炭素最終投与24時間後に.各群のラットにTM
O 100即/kgを経口投与し,その2時間後に採血
し,TMOとその代謝産物ジメタジオン(以下DMO)
の血中濃度をガスクロマトグラフィーにより測定し,得
られた血中濃度の数値からDMO/TMO率を算出した
。24 hours after the final administration of carbon tetrachloride. TM for each group of rats.
O 100/kg was administered orally, 2 hours later blood was collected, and TMO and its metabolite dimethadione (hereinafter referred to as DMO) were collected.
The blood concentration of was measured by gas chromatography, and the DMO/TMO ratio was calculated from the obtained blood concentration value.
(5)試験結果
表2
(3)実験動物:雄性SDラット 7週齢.体重205
〜220, in各4匹
(4)試験方法
雄性SDラットに固形飼料を.1週間自由摂食させた。(5) Test results table 2 (3) Experimental animal: male SD rat, 7 weeks old. Weight 205
~220, in 4 animals each (4) Test method Male SD rats were fed chow. The animals were allowed to eat freely for one week.
ついで卵白酵素分解物.乾燥卵白.又はアミノ混合物投
与に移行すると共に,四塩化炭素1rrcL/kgを移
行日及び5 , 10, 15. 20日目計手法入門
コース.佐久間昭他著.
財団法人 日本科学技術連盟)
●;p<o.os
以上の試験結果は.卵白酵素分解物群のDMO/TMO
率が卵白群及びアミノ酸混合物群よりも有意に高いこと
を示し.これは肝障害時の肝機能の回復力が大きいこ
ある。Next is egg white enzyme decomposition product. Dried egg white. Or transition to amino mixture administration and carbon tetrachloride 1rrcL/kg on the day of transition and 5, 10, 15. 20th day metering method introductory course. Written by Akira Sakuma et al. (Japan Science and Technology Federation) ●;p<o. os The above test results are. DMO/TMO of egg white enzyme decomposition product group
The percentage was significantly higher than that of the egg white group and the amino acid mixture group. This is due to the great ability of liver function to recover from liver damage.
実施例1
組 成
卵白酵素分解物
部分 化デンプン( pcs)
白 糖
とを意味するもので
200g
600 ,
150 y
上記成分をよく混合し,水:エタノール(l:1)混液
100+nLを加え.均一になるようさらによく混合し
た。Example 1 Composition Egg white enzymatic decomposition product Partially converted starch (PCS) White sugar 200g 600, 150 y Mix the above ingredients well, add 100+ nL of water:ethanol (l:1) mixture. The mixture was further mixed well to ensure uniformity.
これを,lsmのスクリーンを装着した円筒造粒機で押
し出し造拉した。そして熱風乾燥機により,50゜Cで
乾燥を行い.顆粒剤を得た。This was extruded and granulated using a cylindrical granulator equipped with an LSM screen. Then, dry at 50°C using a hot air dryer. Granules were obtained.
実施例2
組 成
大豆油
ソルビタンモノウラレート
グリセリールモノステアレート
ショ糖モノステアレート
デキストリン
ビタミン混合物I)
ミネラル混合物0
アラビアガム
精製水
適量
50g
2、5g
2.5g
2.5g
344.5 y
1.Og
12.O Q
5.Og
全量2L
1)ビタミン混合物組成
ビタミンA
// B +
s B t
// B 6
〃B,,
ニコチン酸アミド
パントテン酸カルシウム
葉酸
ビタミンC
〃 D
〃 E
2)ミネラル混合物組成
塩化ナトリウム
炭酸カリウム
水酸化カルシウム
第1リン酸カルシウム
塩化マグネシウム
クエン酸第1鉄
2.500 IU
1.O n
1.5119
3.0即
3.75μg
15.O u
6.5+1!$1
500哩
75■
125IU
15IU
2g
3.8g
O.75 y
2.95 y
3.1g
0.08 y
大豆油にグリセリールモノステアレートとソルビタンモ
ノラウレートを加え,加熱(60〜70℃HI,て溶解
し,これに適当量の精製水を加え混合,した。別途に,
精製水にシヨ糖モノステアレート,卵白酵素分解物,デ
キストリン,ビタミン混合物,ミネラル混合物,アラビ
アガム,セルロースを加え,よく混合した。Example 2 Composition Soybean oil Sorbitan monourarate Glyceryl monostearate Sucrose monostearate Dextrin Vitamin mixture I) Mineral mixture 0 Gum arabic Purified water appropriate amount 50g 2.5g 2.5g 2.5g 344.5 y 1. Og 12. O Q 5. Og Total amount 2L 1) Vitamin mixture composition Vitamin A // B + s B t // B 6 B,, Nicotinamide Calcium pantothenate Folate Vitamin C 〃 D 〃 E 2) Mineral mixture composition Sodium chloride Potassium carbonate Calcium hydroxide Calcium monophosphate Magnesium chloride Ferrous citrate 2.500 IU 1. On 1.5119 3.0 immediately 3.75 μg 15. O u 6.5+1! $1 500 m75■ 125IU 15IU 2g 3.8g O. 75 y 2.95 y 3.1 g 0.08 y Add glyceryl monostearate and sorbitan monolaurate to soybean oil, heat (60-70℃ HI, dissolve), add an appropriate amount of purified water, and dissolve. Mixed.Separately,
Sucrose monostearate, egg white enzyme decomposition product, dextrin, vitamin mixture, mineral mixture, gum arabic, and cellulose were added to purified water and mixed well.
上記の2つの液を混合し,ホモゲナイザーにより乳化し
た後,精製水を加え,全量を2tに調整した。得られた
乳化液を,噴霧乾燥することにより,経口経腸栄養剤粉
末約450gを得た。After the above two liquids were mixed and emulsified using a homogenizer, purified water was added to adjust the total amount to 2 tons. The obtained emulsion was spray-dried to obtain about 450 g of oral and enteral nutritional powder.
実施例3
組 成
卵白酵素分解物
砂糖3096混合ぶどう糖果糖液糖
クエン酸(結晶)
プルーンエキス
リンゴ透明果汁(1/5濃縮)
カラメル
20.O y
150g
2.O y
1.Og
3.0g
1.0g
精製水
適量
全i!kIL
プルーンエキスを精製水の1部で希釈した後,濾過した
。得られた溶液に,別途に,精製水の1部に,砂糖30
%混合ぶどう糖果糖液糖,クエン酸,卵白酵素分解物,
リンゴ透明濃縮果汁(1/5111縮)を加え.よく混
合した。Example 3 Composition Egg white enzymatic decomposition product Sugar 3096 mixed glucose High fructose corn syrup Citric acid (crystal) Prune extract Apple clear juice (1/5 concentration) Caramel 20. O y 150g 2. O y 1. Og 3.0g 1.0g Appropriate amount of purified water all i! The kIL prune extract was diluted with one part of purified water and then filtered. Separately, add 30 ml of sugar to 1 part of purified water to the resulting solution.
% mixed glucose fructose corn syrup, citric acid, egg white enzyme decomposition product,
Add clear concentrated apple juice (1/5111 reduction). Mix well.
こうして得られたものにカラメル,スモモエッセンスを
加え,精製水で全量をILに調整した後,よく混合した
。得られたスモモ風味のジュースを瓶に分注し.密栓し
た後,浸漬殺菌(808C10分間)を行い,製品を得
た。Caramel and plum essence were added to the mixture thus obtained, the total amount was adjusted to IL with purified water, and the mixture was thoroughly mixed. Pour the resulting plum-flavored juice into bottles. After sealing the container, immersion sterilization (808C for 10 minutes) was performed to obtain a product.
実施例4
生卵に卵白酵素分解物,ココ乙 くるみを加えてよく混
合し,これにバターと砂糖をよ《練合したものを加えた
。Example 4 Enzymatically digested egg white and walnuts were added to raw eggs and mixed well, and then a well-kneaded mixture of butter and sugar was added.
これに,別途調整したクエン酸鉄,炭酸カルシウム,小
麦粉,重ソウの混合物を,少しずつ加え,練合した。A separately prepared mixture of iron citrate, calcium carbonate, wheat flour, and heavy sourdough was added little by little and kneaded.
このようにして得られた生地を,型に入れて成形し,
(180゜C,15分)で焼きあげて,ビスケット約1
00gを得た。The dough obtained in this way is put into a mold and shaped.
(180°C, 15 minutes), about 1 biscuit
00g was obtained.
卵白酵素分解物 小麦粉 バター 砂糖 生卵 《るみ ココア ビタミン混合 クエン酸鉄 炭酸カルシウム 4g 50 y 20 y 25 y 15y 3g 4g 0.5g 501llg 7681nQ 唇詩汽ル、人 エーザイオ禾K金ネムEgg white enzyme decomposition product flour butter sugar Raw egg 《Rumi cocoa vitamin mixture iron citrate calcium carbonate 4g 50y 20y 25y 15y 3g 4g 0.5g 501llg 7681nQ lip poem, person Eisai K. Kinnemu
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1115122A JPH02295463A (en) | 1989-05-10 | 1989-05-10 | Food material for improving hepatic function |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1115122A JPH02295463A (en) | 1989-05-10 | 1989-05-10 | Food material for improving hepatic function |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02295463A true JPH02295463A (en) | 1990-12-06 |
Family
ID=14654807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1115122A Pending JPH02295463A (en) | 1989-05-10 | 1989-05-10 | Food material for improving hepatic function |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02295463A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005074703A1 (en) * | 2004-02-10 | 2005-08-18 | Join Co. Ltd | A process for preparing an egg white liquid for prevention of coagulation due to heat treatment |
WO2011040141A1 (en) * | 2009-09-30 | 2011-04-07 | 理研ビタミン株式会社 | Composition containing fat-soluble vitamin |
-
1989
- 1989-05-10 JP JP1115122A patent/JPH02295463A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005074703A1 (en) * | 2004-02-10 | 2005-08-18 | Join Co. Ltd | A process for preparing an egg white liquid for prevention of coagulation due to heat treatment |
WO2011040141A1 (en) * | 2009-09-30 | 2011-04-07 | 理研ビタミン株式会社 | Composition containing fat-soluble vitamin |
JPWO2011040141A1 (en) * | 2009-09-30 | 2013-02-21 | 理研ビタミン株式会社 | Fat-soluble vitamin-containing composition |
JP5836127B2 (en) * | 2009-09-30 | 2015-12-24 | 理研ビタミン株式会社 | Fat-soluble vitamin-containing composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2603518C (en) | Nutrient composition for promoting collagen production | |
JP4970694B2 (en) | Persistent muscle fatigue improver | |
KR101110983B1 (en) | Accelerator for mineral absorption and use thereof | |
KR20100018568A (en) | Novel sweetener having sugar-like taste and production method and use of the same | |
CN105166759B (en) | A kind of high dietary-fiber coconut powder and application thereof | |
PT2117338E (en) | Partially hydrolysed cereal protein | |
CN102428094A (en) | Collagen peptide composition having good blood transfer properties, and food and drink containing same | |
JP5442243B2 (en) | Renal disorder inhibitor | |
CN111802653A (en) | Tuna oligopeptide powder composition and preparation method and application thereof | |
JP4596513B2 (en) | Nutritional composition | |
CN109247482A (en) | Diabetic's solid beverage and preparation method thereof | |
CN107821713A (en) | Collagen mineral complex pressed candy | |
JP5937884B2 (en) | Food and drink | |
EP2030629B1 (en) | Alpha-s-casein as lipid-metabolism-improving agent | |
JP2010173962A (en) | Glycolytic enzyme inhibitor derived from wheat endosperm and cholesterol-lowering composition containing dietary fiber | |
JP5281895B2 (en) | Calcium absorption promoter | |
JP4673071B2 (en) | Iron-adsorptive polymer substance, iron-containing polymer substance, and production method thereof | |
JP3979543B2 (en) | Antiallergic agent and method for producing the same | |
JPH02295463A (en) | Food material for improving hepatic function | |
JP5222299B2 (en) | Fat absorption inhibiting composition | |
JP2008184459A (en) | Calcium absorption accelerating composition | |
JP2002000226A (en) | Food containing barley young leaf powder | |
KR20040044939A (en) | Compositions for appetite control and related methods | |
JPS60186261A (en) | Solid food composition | |
KR100228743B1 (en) | A confectionery composition having high energy |